Akero's NASH miss drags a few peers down, spurring deja vu in long-challenging indicationAkero's NASH miss drags a few peers down, spurring deja vu in long-challenging indication - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 12, 2023 at 2:50 PM in business No comments 63